Clearside Biomedical

+$0.03 (+2.29%) Today
$0.00 (0.00%) As of 9:16 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy.

CEO
George M. Lasezkay
Employees
34
Headquarters
Alpharetta, Georgia
Founded
2011

CLSD Key Statistics

Market cap
80.60M
Price-Earnings ratio
—
Dividend yield
—
Average volume
206.86K
High today
$1.35
Low today
$1.30
Open price
$1.32
Volume
166.76K
52 Week high
$7.73
52 Week low
$1.28

CLSD Earnings

-$0.14
$0.01
$0.16
$0.31
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure